The sphingolipid signaling pathway is also frequently activated in IDH-mutant gliomas, and inhibition of sphingosine kinase I (SphK1) with N,N-dimethylsphingosine (DNMS) specifically leads to cell death in IDH1-mutant gliomas [29]. Here, IDH2 is linked to central nervous system cancer.